Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Auto vs Auto-Allo Transplant in Multiple Myeloma (BMT CTN 0102)
NCT00075829Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2003
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide, dexamethasone in multiple myeloma (MM), sponsored by National Heart, Lung, and Blood Institute. Started Dec 2003; status: completed.
02
Drugs
thalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00075829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075829.